Teva Didn't Infringe Purdue Pharma's OxyContin Patents, NY Judge Rules

Published January 15, 2014

Teva Didn't Infringe Purdue Pharma's OxyContin Patents, NY Judge Rules
In April, Purdue settled a patent-infringement lawsuit against Actavis Inc.(ACT) over OxyContin, a narcotic used to treat pain from cancer and other conditions that can also be abused by addicts. In a statement at the time the companies said that … Read more on Jewish Business News

Company key to overcoming addiction
LAB TEST: Socially dominant monkeys, when put in social groups, were less likely to resume their cocaine habit. … One of the obstacles facing those who have opted for inpatient treatment programmes is that such programmes are typically short- lived. Read more on Timaru Herald